Revisiting Repurposing.
Sharlow ER.
Assay Drug Dev Technol. 2016 Dec;14(10):554-556. doi: 10.1089/adt.2016.766.
Ampicillin.
Bear DM, Turck M, Petersdorf RG.
Med Clin North Am. 1970 Sep;54(5):1145-59.
[Antiandrogens].
Neumann F.
Med Klin. 1973 Mar 16;68(11):329-33.
Network-based drug repositioning.
Wu Z, Wang Y, Chen L.
Mol Biosyst. 2013 Jun;9(6):1268-81. doi: 10.1039/c3mb25382a. Epub 2013 Mar 14.
Rifampicin: a review.
[No authors listed]
Drugs. 1971;1(5):354-98. doi: 10.2165/00003495-197101050-00002.
Dopamine and disease.
Barbeau A.
Can Med Assoc J. 1970 Oct 17;103(8):824-32.
Factors affecting nasal drug delivery and design strategies for intranasal drug delivery.
Hu X, Yue X, Wu C, Zhang X.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023 Jun 25;52(3):328-337. doi: 10.3724/zdxbyxb-2023-0069.
Clinical implications from drug-drug and drug-disease interactions in older people.
Gnjidic D, Johnell K.
Clin Exp Pharmacol Physiol. 2013 May;40(5):320-5. doi: 10.1111/1440-1681.12081.
Herb-drug interactions involving drug metabolizing enzymes and transporters.
Liu CX, Yi XL, Si DY, Xiao XF, He X, Li YZ.
Curr Drug Metab. 2011 Nov;12(9):835-49. doi: 10.2174/138920011797470083.
Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs.
Shitara Y, Sato H, Sugiyama Y.
Annu Rev Pharmacol Toxicol. 2005;45:689-723. doi: 10.1146/annurev.pharmtox.44.101802.121444.
